Poelstra K, Heynen E R, Baller J F, Hardonk M J, Bakker W W
Department of Pathology, University of Groningen, The Netherlands.
Lab Invest. 1992 May;66(5):555-63.
Extracellular adenine nucleotides are considered mediators of inflammation because they modulate functions of neutrophils and platelets. Until now, this role for adenine nucleotides has not been studied in vivo. In particular in the rat kidney, where ATP- and ADPase activity is present in the glomerular basement membrane, studies about the role of nucleotides may increase our understanding of the dynamics of glomerulonephritis (GN). Therefore, we examined effects of adenine derivatives ATP gamma S, ADP beta S and 2chloro-adenosine (2chloro-ADO) in vitro and during anti-Thy1 GN. The in vitro results show that ADP beta S and ATP gamma S are not degraded by glomerular nucleotidases but, on the other hand do stimulate O2- production of peritoneal exudate cells (PEC). In contrast, 2chloro-ADO significantly inhibits O2- production of peritoneal exudate cells. For in vivo studies rats were rendered nephritic by intravenous injection of monoclonal anti-Thy1 IgG (5 mg/kg body weight). Subsequently, rats were treated with saline (group 1, N = 10), 2chloro-ADO (group 2, N = 10), ADP beta S (group 3, N = 10) or ATP gamma S (group 4, N = 10). All analogs (10 mg/kg body weight) were administered both at t = 0 and t = 12 hour. After 24 hours, rats were sacrificed and kidneys were examined histochemically. In an additional group of nephritic rats (N = 5) proteinuria was studied after 2-chloro-ADO treatment. Results show increased intraglomerular platelet aggregation in nephritic rats treated with ADP beta S, whereas 2chloro-ADO inhibits aggregation significantly as compared with nephritic rats receiving saline. The percentage of granulocytes producing O2- is significantly increased in glomeruli after treatment of nephritic rats with ATP gamma S, whereas cell influx itself is not changed. In contrast, 2chloro-ADO inhibits intraglomerular O2- production, which is associated with the complete inhibition of proteinuria in the early phase of anti-Thy1 GN. These data demonstrate significant pro-inflammatory activities of extracellular adenine nucleotides during anti-Thy1 GN suggesting an anti-inflammatory role for glomerular ATP/ADPase, which in concert with 5' nucleotidase converts ATP and ADP to antiinflammatory ADO.
细胞外腺嘌呤核苷酸被认为是炎症介质,因为它们可调节中性粒细胞和血小板的功能。到目前为止,腺嘌呤核苷酸的这一作用尚未在体内进行研究。特别是在大鼠肾脏中,肾小球基底膜存在ATP和ADP酶活性,对核苷酸作用的研究可能会增加我们对肾小球肾炎(GN)动态变化的理解。因此,我们研究了腺嘌呤衍生物ATPγS、ADPβS和2-氯腺苷(2-氯-ADO)在体外以及在抗Thy1肾小球肾炎期间的作用。体外实验结果表明,ADPβS和ATPγS不会被肾小球核苷酸酶降解,但另一方面会刺激腹腔渗出细胞(PEC)产生超氧阴离子(O₂⁻)。相比之下,2-氯-ADO可显著抑制腹腔渗出细胞产生O₂⁻。在体内研究中,通过静脉注射单克隆抗Thy1 IgG(5 mg/kg体重)使大鼠患肾炎。随后,大鼠分别接受生理盐水治疗(第1组,N = 10)、2-氯-ADO治疗(第2组,N = 10)、ADPβS治疗(第3组,N = 10)或ATPγS治疗(第4组,N = 10)。所有类似物(10 mg/kg体重)均在t = 0和t = 12小时给药。24小时后,处死大鼠并对肾脏进行组织化学检查。在另一组患肾炎的大鼠(N = 5)中,研究了2-氯-ADO治疗后的蛋白尿情况。结果显示,接受ADPβS治疗的患肾炎大鼠肾小球内血小板聚集增加,而与接受生理盐水治疗的患肾炎大鼠相比,2-氯-ADO可显著抑制聚集。用ATPγS治疗患肾炎大鼠后,肾小球内产生O₂⁻的粒细胞百分比显著增加,而细胞流入本身并未改变。相比之下,2-氯-ADO可抑制肾小球内O₂⁻的产生,这与抗Thy1肾小球肾炎早期蛋白尿的完全抑制有关。这些数据表明,在抗Thy1肾小球肾炎期间,细胞外腺嘌呤核苷酸具有显著的促炎活性,提示肾小球ATP/ADP酶具有抗炎作用,它与5'-核苷酸酶协同作用将ATP和ADP转化为抗炎性的ADO。